Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hartmut Goldschmidt
The CCND1 C.870G>A Polymorphism Is a Risk Factor for T(11;14)(q13;q32) Multiple Myeloma
Nature Genetics
Genetics
Pomalidomide Plus Low-Dose Dexamethasone Versus High-Dose Dexamethasone Alone for Patients With Relapsed and Refractory Multiple Myeloma (MM-003): A Randomised, Open-Label, Phase 3 Trial
The Lancet Oncology
Oncology
Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Siltuximab in High-Risk Smoldering Multiple Myeloma
Clinical Cancer Research
Cancer Research
Oncology
High Sub-Clonal Fraction of 17p Deletion Is Associated With Poor Prognosis in Multiple Myeloma
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Patients With Precursor Disease Exhibit Similar Psychological Distress and Mental HRQOL as Patients With Active Myeloma
Blood Cancer Journal
Oncology
Hematology
European Perspective on Multiple Myeloma Treatment Strategies: Update Following Recent Congresses
Oncologist
Cancer Research
Medicine
Oncology
DNMTi/HDACi Combined Epigenetic Targeted Treatment Induces Reprogramming of Myeloma Cells in the Direction of Normal Plasma Cells
British Journal of Cancer
Cancer Research
Oncology
Cell-Based Immunotherapy Approaches for Multiple Myeloma
British Journal of Cancer
Cancer Research
Oncology
Increased Microcirculation Detected by Dynamic Contrast-Enhanced Magnetic Resonance Imaging Is of Prognostic Significance in Asymptomatic Myeloma
British Journal of Haematology
Hematology
miRNAs in Multiple Myeloma &Ndash; A Survival Relevant Complex Regulator of Gene Expression
Oncotarget
Oncology
1
2
›
